Viewing StudyNCT00192101



Ignite Creation Date: 2024-05-05 @ 11:57 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00192101
Status: COMPLETED
Last Update Posted: 2007-11-20
First Post: 2005-09-12

Brief Title: Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines andor Taxanes
Sponsor:
Organization: Eli Lilly and Company